Shared decision making of burdensome surveillance tests using personalized schedules and their burden and benefit

Benchmark surveillance tests for detecting disease progression (eg, biopsies, endoscopies) in early‐stage chronic noncommunicable diseases (eg, cancer, lung diseases) are usually burdensome. For detecting progression timely, patients undergo invasive tests planned in a fixed one‐size‐fits‐all manner...

Descripción completa

Detalles Bibliográficos
Autores principales: Tomer, Anirudh, Nieboer, Daan, Roobol, Monique J., Steyerberg, Ewout W., Rizopoulos, Dimitris
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9305929/
https://www.ncbi.nlm.nih.gov/pubmed/35146793
http://dx.doi.org/10.1002/sim.9347

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9305929/
https://www.ncbi.nlm.nih.gov/pubmed/35146793
http://dx.doi.org/10.1002/sim.9347

Ejemplares similares